Economic Considerations and Cost-Saving Strategies for Nonsterile Compounding Education.
Budget
Cost
Equipment
Nonsterile compounding
Personnel
Journal
American journal of pharmaceutical education
ISSN: 1553-6467
Titre abrégé: Am J Pharm Educ
Pays: United States
ID NLM: 0372650
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
27
10
2022
revised:
20
06
2023
accepted:
05
07
2023
medline:
3
11
2023
pubmed:
17
7
2023
entrez:
16
7
2023
Statut:
ppublish
Résumé
To determine the economic considerations, including cost-saving strategies, associated with nonsterile compounding education for students in schools and colleges of pharmacy across the United States. An electronic survey was sent to the American Association of Colleges of Pharmacy Pharmaceutics Section and Laboratory Instructor's Special Interest Group members. Quantitative and qualitative data were collected about the institution, student cohorts, compounding courses, equipment, budgets, personnel, and cost-saving measures. Descriptive statistics were calculated using SPSS. Open-ended responses were used by respondents if the primary question could not adequately capture their institution-specific information. These answers were added to the study findings. Of 555 surveys sent, 46 were completed. Reported annual compounding budgets ranged from $3000 to $96,000. Reported annual equipment maintenance costs ranged from $400 to $18,000. Fifty percent of respondents reported students shared equipment, and 29.6% collected a lab fee from students to offset costs. Approximately half of respondents reported the use of cost-saving measures, including contract pricing, purchasing supplies in bulk, price comparisons, use of simulated drugs, re-use of personal protective equipment, and procurement of donations. Fifty percent of respondents employed laboratory assistants to support nonsterile compounding sessions, with paid positions ranging from $200 to $1000 per semester. Findings from this study may assist pharmacy administrators and course directors in evaluating the costs associated with nonsterile compounding education across the Academy and, more importantly, determining ways to reduce such costs while maintaining the intent and quality of these courses.
Identifiants
pubmed: 37454811
pii: S0002-9459(23)01898-3
doi: 10.1016/j.ajpe.2023.100571
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100571Informations de copyright
Copyright © 2023 American Association of Colleges of Pharmacy. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.